Skip to main content
. Author manuscript; available in PMC: 2014 Apr 10.
Published in final edited form as: Mol Cell Endocrinol. 2012 May 17;368(1-2):17–29. doi: 10.1016/j.mce.2012.05.004

Figure 1. Reported FXR ligands.

Figure 1

(A) FXR agonists, CDCA (steroid), farnesol (terpenoid), GW4064 (aromatics), and WAY-362450 (alkaloid). (B) FXR antagonists, AGN-34 (aromatics), linolenic acid (fatty acid), guggulsterone (steroid), oleanoic acid (terpenoid).